FIZZ

National Beverage Corp

Consumer


Presented:10/19/2016
Price:$48.75
Cap:$2.28B
Current Price:$45.98
Cap:$4.30B

Presented

Date10/19/2016
Price$48.75
Market Cap$2.28B
Ent Value$2.55B
P/E Ratio31.25x
Book Value$5.06
Div Yield0%
Shares O/S46.77M
Ave Daily Vol434,060
Short Int22.40%

Current

Price$45.98
Market Cap$4.30B
National Beverage Corp. develops, manufactures, markets and sells a diverse portfolio of flavored beverage products. Its brands include Shasta, Faygo, Everfresh, LaCroix, Rip It, Asante, Mt. Shasta, ClearFruit, Mr. Pure, Ritz, Crystal Bay, Cascadia Sparkling Clear, Cascadia Only 2 Calories, Ohana, Big Shot and St. Nick's. The company was founded by Nick A. Caporella in 1985 and is headquartered in Fort Lauderdale, FL.

Publicly traded companies mentioned herein: The Coca-Cola Company (KO), National Beverage Corp (FIZZ), Nielsen Holdings plc (NLSN), Pepsico Inc (PEP)

Highlights

National Beverage Corp (FIZZ) has seen its shares decline following the release of a research note by Glaucus Research Group, a California-based short seller. The stock had traded as high as the low $60s in July (2016) based on the strength of its LaCroix seltzer brand; however, the stock backed off to the $50s and then the presenter said the publication of the short thesis (9/27/16) drove shares to a low of $39. The presenter is presently long FIZZ, and said he originally bought stock in the mid-$40s and added to the position when it traded down on the Glaucus note. The main points in the short thesis relate to questionable accounting methods and the ownership structure, and it was even suggested that FIZZ’s founder and CEO Nick Caporella has manipulated earnings results. However, the presenter has reviewed the company’s accounting and disagrees with much of the short thesis. In particular, Glaucus largely ignores LaCroix’s positioning in the market and potential future earnings power (sales jumped from $65 million in 2010 to $226 million in 2015). Plus, with over $100 million in cash on the balance sheet and no debt to speak of the risk/ reward appears to be favorable. In his opinion, the stock could trade up to $70+ in 12 months (26x $2.70 of EPS in FY 2018) from ~$50.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.